LatAm From the perspective of international pharmaceuticals developers, Latin America can be considered a region of exceptional potential owing to solid market fundamentals and significant untapped opportunities. “I am convinced that we are poised to become among the most dynamic regions for growth momentum globally driven by multiple factors: among them…
LatAm When it comes to pharmaceutical exports, Latin America has historically been confined to the margins of the global life science industry. In 2023, the region accounted for a mere one percent of worldwide pharmaceutical exports, down from 1.97 percent a decade earlier, despite housing over eight percent of the world’s…
ALIFAR At its recent assembly in Bogotá, ALIFAR – the Latin American Association of National Pharmaceutical Industries – brought together chambers from 14 countries to set a shared agenda for 2025. Representing hundreds of laboratories and thousands of workers, ALIFAR is working to strengthen the region’s pharmaceutical base through sovereignty, innovation,…
See our Cookie Privacy Policy Here
